Zifivax, an mRNA-based Covid-19 vaccine developed by Anhui Zhifei Longcom Pharmaceutical (China), has just secured Emergency Use Authorization (EUA) from Indonesian Food and Drug Administration (BPOM). Like China Sinovac, which is locally produced by state vaccine producer Biofarma, Anhui has been working with private companies in Indonesia to produce Zifivax locally. To subscribe please click here
